Evidence map›Paper›PMID 28085209›Full record

ReviewHepatology (Baltimore, Md.)2017

Augmenter of liver regeneration: A fundamental life protein.

Michael A Nalesnik, Chandrashekhar R Gandhi, Thomas E Starzl

Abstract readReview
In one paragraph

Review in Hepatology (Baltimore, Md.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  13. Article
  14. Article
  15. Thomas E. Starzl: Transplantation pioneer.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael A NalesnikDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA.
Chandrashekhar R GandhiDepartment of Pediatrics, Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Thomas E StarzlThomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.

Funding

Mechanisms of Alcoholic Liver DiseaseR21AA020846 · NIAAA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GANDHI, CHANDRASHEKHAR R · 2012 to 2013
$344k
Mechanisms of Liver InjuryI01BX001174 · VA · VETERANS HEALTH ADMINISTRATION · PI GANDHI, CHANDRASHEKHAR R · 2012 to 2023
–
BLRD VA I01 BX001174NIAAA NIH HHS R21 AA020846
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsHumansOxidoreductases Acting on Sulfur Group DonorsGFER protein, humanOxidoreductases Acting on Sulfur Group Donors

Identifiers

PMID28085209
PMCPMC5682950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.